Nonetheless, among HLA-eligible patients with HNSCC, melanoma, or UC, the frequency of positivity for the MAGE-A10 antigen was lower than expected, making enrollment challenging. Here, MAGEA10 is linked to head and neck squamous cell carcinoma.